Public procurement notice: Voluntary Ex Ante Transparency Notice
Published: 2022-12-09
Buyer: SYKEHUSINNKJØP HF
Country: NO
Contract type: Supplies
Procedure: Contract award without prior publication
CPV classification: 33600000: Pharmaceutical products
Estimated value: 1750000 NOK
Award criteria: Lowest price

Technical requirements: Sykehusinnkjøp HF, Divisjon legemidler [the Norwegian Hospital Procurement Trust, the Pharmaceutical Division] is collecting tenders for pharmaceuticals used by the health trusts. Sykehusinnkjøp HF has previously published and conducted an open tender contest for Non-patented oncology medicines, injection infusion, unregistered (2207j). The competition includes active ingredients in accordance with the tender documentation, annex 3 - the Active Ingredients List.
There was only one tenderer that presented a tender for relevant the sub-delivery (sub-delivery 8, ATC code L01DA01, Dactinomycin). After the contract was signed, the tenderer notified us that they cannot deliver, and the contract was terminated. Therefore, there is a need to enter into a new contract with a new supplier.
Due to this, Sykehusinnkjøp HF intends to enter into contracts between the regional health trusts (the Contracting Authorities) and Farma Mondo ApS (the Supplier) as an additional contract to LIS LIS 2207j. I.e., the scope and length of the contract must follow the mentioned procurement (including access to extensions and terminations), without a new tender contest being held for this ingredient. The health trusts that are under the regional health authorities have options for enter the agreements. The same applies for non-profit institutions/hospitals with an operational contract with each health region.
Sykehusinnkjøp HF, divisjon legemidler has explored the market situation and is of the opinion that it is impossible to carry out a new invitation to tender, or that a supplier other than Farma Mondo ApS can deliver the product in the impending contract period, and that the situation that has occurred is not the contracting authority’s fault, nor something that the contracting authority could predict. We therefore believe that there are grounds to make the procurement without an invitation to tender. See the public procurement regulations §21-5, c.f. § 21-2, c.f. § 13-4 letter b no. 3 and letter cf. also § 13-3 letter e.
Sykehusinnkjøp HF requests that those who have objections to contract award to submit feedback before the waiting period expires on 14.08.2022. If no objections are received, contracts will be signed after the waiting period has expired.
Sykehusinnkjøp HF, divisjon legemidler, has explored the market situation and is of the opinion that it is impossible to carry out a new invitation to tender, or that a supplier other than Aspen Pharma can deliver the product in the impending contract period, and that the situation that has occurred is not the contracting authority’s fault, nor something that the contracting authority could predict. LIS [the Pharmaceutical Division] therefore believes that there are grounds to make the procurement without an invitation to tender. See the public procurement regulations §21-5, c.f. § 21-2, c.f. § 13-4 letter b no. 3 and letter cf. also § 13-3 letter e.


Winner: Farma Mondo Nordic ApS
Award value: 1750000